CLINICAL_TRIALS
trial_result
· 2021-09-24
Clinical Trial Update: Arformoterol/Budesonide for COVID-19 [Phase 2]
Summary
Phase 2 clinical trial investigating arformoterol/budesonide for coronavirus infection (COVID-19) is in an unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Korea United Pharm. Inc. | Conditions: Coronavirus Infection | Phase 2 | Status: UNKNOWN